| ○ |
|
上田 龍三 |
愛知医科大学・教授 |
| 腫瘍免疫 |
| Strategy for preventing hepatitis B reactivation in patients with resolved HBV infection following rituximab-containing chemotherapy. Kusumoto S, Tanaka Y, Mizokami M, Ueda R. Hepatology.; 60(2):765-6, 2014. |
| HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantationJ Immunol, Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, Yamada T, Ri M, Kusumoto S, Komatsu H, Miyazaki Y, Takatsuka Y, Utsunomiya A, Niimi A, Iida S, Ueda R. J Immunol. 192(3):940-7. 2014. |
| Multicenter phase II study of Mogamulizumab (KW-0761), a defucosylated anti-CC chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Ogura M, Ishida T, Hatake K, Taniwaki M, Ando K, Tobinai K, Fujimoto K, Yamamoto K, Miyamoto T, Uike N, Tanimoto M, Tsukasaki K, Ishizawa K, Suzumiya J, Inagaki H, Tamura K, Akinaga S, Tomonaga M Ueda R: J Clin Oncol. 32(11):1157-63, 2014. |
|
| |
|
北川雄光 |
慶應義塾大学外科・教授 |
| 外科 |
| Takeuchi H, Miyata H, Gotoh M, Kitagawa Y, Baba H, Kimura W, Tomita N, Nakagoe T, Shimada M, Sugihara K, Mori M. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg 260(2): 259-66, 2014.08 |
| Kitagawa Y, Takeuchi H, Takagi Y, Natsugoe S, Terashima M, Murakami N, Fujimura T, Tsujimoto H, Hayashi H, Yoshimizu N, Takagane A, Mohri Y, Nabeshima K, Uenosono Y, Kinami S, Sakamoto J, Morita S, Aikou T, Miwa K, Kitajima M. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol. 31(29): 3704-10, 2013.10 |
| Takeuchi H, Kitagawa Y. New Sentinel Node Mapping Technologies for Early Gastric Cancer. Annals of Surgical Oncology 20(2): 522-532, 2013.02 |
|
| |
|
小西 郁生 |
京都大学大学院医学研究科 器官外科学講座
婦人科学産科学分野・教授
|
| 産科婦人科学（婦人科腫瘍学） |
(1) Peng J, Yoshioka Y, Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Kharma B, Murakami R, Abiko K, Murphy SK, Konishi I.
The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-a potential therapeutic target.
Mol Carcinog. 2015 Feb 7. [Epub ahead of print]
|
(2) Matsumoto K, Katsumata N, Shibata T, Satoh T, Saitou M, Yunokawa M, Takano T, Nakamura K, Kamura T, Konishi I.
Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503).
Gynecol Oncol. 2015 Feb;136(2):218-23.
|
(3) Kharma B, Baba T, Matsumura N, Kang HS, Hamanishi J, Murakami R, McConechy MM, Leung S, Yamaguchi K, Hosoe Y, Yoshioka Y, Murphy SK, Mandai M, Hunstman DG, Konishi I.
STAT1 drives tumor progression in serous papillary endometrial cancer.
Cancer Res. 2014 Nov 15;74(22):6519-30.
|
|
| |
|
坂元昇 |
川崎市健康福祉局 |
| 公衆衛生、精神医学 |
| 大規模災害における広域（都道府県）支援体制 − 東日本大震災の自治体による保健医療福祉支援の実態と今後の巨大地震に備えた効率的・効果的支援のあり方について、坂元昇、保健医療科学 2013、Vol.６２、4号、pp396−404 |
| 大気汚染と健康被害への再考-川崎市における40年間にわたる気管支喘息罹患率と大気汚染物質濃度との経年推移の比較研究、坂元昇、日本職業・環境アレルギー学会雑誌、2014、Vol.21 2号、pp33−44 |
| 平成23年度地域保健総合推進事業 東日本大震災被災市町村への中長期的公衆衛生支援のあり方に関する提言 「全国の自治体等による東日本大震災被災地への保健医療福祉支援実態調査報告書」、坂元昇、2012、日本公衆衛生協会 |
|
| |
|
祖父江 友孝 |
大阪大学大学院医学系研究科教授 |
| がん疫学 |
| Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Sobue T, Yamamoto S, Hara M, Sasazuki S, Sasaki S, Tsugane S. Int J Cancer. 2002; 99: 245-251. |
| Screening for lung cancer with low-dose helical computed tomography: Anti-Lung Cancer Association Project. Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, Kakinuma R, Ohmatsu H, Nagai K, Nishiyama H, Matsui E, Eguchi K. J Clin Oncol. 2002; 20: 911-20. |
| A case-control study for evaluating lung-cancer screening in Japan. Sobue T, Suzuki T, Naruke T. Int J Cancer. 1992; 50:230-7. |
|
| |
|
梛野 正人 |
名古屋大学医学部腫瘍外科教授 |
| 消化器外科（肝胆膵外科） |
Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Ann Surg 2006;243:364-372
|
| Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma. Nagino M, Nimura Y, Nishio H, Ebata T, Igami T, Matsushita M, Nishikimi N, Kamei Y. Ann Surg 2010;252:115-123. |
| Evolution of surgical treatment for perihilar cholangiocarcinoma: A single center 34-year review with 574 consecutive resections. Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y. Ann Surg 2013;258:129-140. |
|
| |
|
野田 哲生 |
公益財団法人がん研究会
代表理事・常務理事 がん研究所 所長
|
| 分子遺伝学 |
| H. Takeshima, M. Iino, H. Takekura, M. Nishi, J. Kuno, O. Minowa, H. Takano and T. Noda. (1994) Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature, 369: 556-559. |
| H. Shibata, K. Toyama, H. Shioya, M. Ito, M. Hirota, S. Hasegawa, H. Matsumoto, H. Takano, T. Akiyama, K. Toyoshima, R. Kanamaru, Y. Kanegae, I. Saito, Y. Nakamura, K. Shiba and T. Noda. (1997) Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science, 278: 120-123. |
| R. Yao, Y. Kondoh, Y. Natsume, H. Yamanaka, M. Inoue, H. Toki, R. Takagi, T. Shimizu, T. Yamori, H. Osada and T. Noda. (2014) A small compound targeting TACC3 revealed its different spatiotemporal contributions for spindle assembly in cancer cells. Oncogene, 33: 4242-4252. |
|
| |
|
眞島 喜幸 |
特定非営利活動法人パンキャンジャパン 理事長 |
| 患者アドボカシー、がん研究支援 |
| がん政策研究の分野に関わる業績なし |
|
| |
|
門田 守人 |
がん研有明病院・病院長 |
| 消化器外科 |
| Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. Ritchie SA1, Akita H, Takemasa I, Eguchi H, Pastural E, Nagano H, Monden M, et al. BMC Cancer. 2013 Sep 12;13:416. |
| 5-fluorouracil arterial infusion + interferon therapy for highly advanced hepatocellular carcinoma: A multicenter, randomized, phase II study. Monden M, Sakon M, Sakata Y, Ueda Y, Hashimura E; FAIT Research Group. Hepatol Res. 2012 Feb;42(2):150-65. |
| Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma. Eguchi S, Kanematsu T, Arii S, Omata M, Kudo M, Sakamoto M, Takayasu K, Makuuchi M, Matsuyama Y, Monden M; Liver Cancer Study Group of Japan. Br J Surg. 2011 Apr;98(4):552-7. |
|
